Targeting STAT5B in T-cell acute lymphoblastic leukemia.

STAT5 Transcription Factor; STAT5B protein, human; Humans; STAT5 Transcription Factor/genetics; STAT5 Transcription Factor/metabolism; T-Lymphocytes/metabolism; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Precursor Cells, T-Lymphoid; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes; Biochemistry; Immunology; Hematology; Cell Biology

Disciplines :

Oncology

Author, co-author :

Bacquelaine Veloso, Alexandra ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Virologie - Immunologie

Cools, Jan; KU Leuven ; VIB

Language :

English

Title :

Targeting STAT5B in T-cell acute lymphoblastic leukemia.

Publication date :

20 July 2023

Journal title :

Blood

ISSN :

0006-4971

eISSN :

1528-0020

Publisher :

Elsevier B.V., United States

Volume :

142

Issue :

Pages :

215 - 217

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://ashpublications.org/blood/article-pdf/142/3/215/2066734/blood_bld-2023-020639-c-main.pdf

Available on ORBi :

since 04 January 2026

Statistics

Number of views

8 (0 by ULiège)

Number of downloads

11 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Tremblay, CS, Saw, J, Boyle, JA, et al. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia. Blood 142:3 (2023), 274–289.
Vainchenker, W, Constantinescu, SN, JAK/STAT signaling in hematological malignancies. Oncogene 32:21 (2013), 2601–2613.
Constantinescu, SN, Vainchenker, W, Levy, G, Papadopoulos, N, Functional consequences of mutations in myeloproliferative neoplasms. Hemasphere, 5(6), 2021, e578.
Kollmann, S, Grausenburger, R, Klampfl, T, et al. A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells. Blood 138:23 (2021), 2347–2359.
Girardi, T, Vicente, C, Cools, J, De Keersmaecker, K, The genetics and molecular biology of T-ALL. Blood 129:9 (2017), 1113–1123.
Tate, JG, Bamford, S, Jubb, HC, et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res 47:D1 (2019), D941–D947.
de Araujo, ED, Erdogan, F, Neubauer, HA, et al. Structural and functional consequences of the STAT5BN642H driver mutation. Nat Commun, 10(1), 2019, 2517.
Maude, SL, Dolai, S, Delgado-Martin, C, et al. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. Blood 125:11 (2015), 1759–1767.
Subramaniam, D, Angulo, P, Ponnurangam, S, et al. Suppressing STAT5 signaling affects osteosarcoma growth and stemness. Cell Death Dis, 11(2), 2020, 149.
Nelson, EA, Walker, SR, Weisberg, E, et al. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood 117:12 (2011), 3421–3429.
Rondanin, R, Simoni, D, Romagnoli, R, et al. Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives. Bioorg Med Chem Lett 24:18 (2014), 4568–4574.